| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Sep'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Expenses | |||||||||||||
Research and development | |||||||||||||
15,974 | 15,616 | 14,070 | 12,099 | 9,408 | 7,761 | 6,047 | 5,488 | 4,409 | 3,208 | 0 | 0 | 0 | 0 |
General and administrative | |||||||||||||
7,359 | 6,465 | 6,074 | 5,675 | 4,925 | 4,155 | 3,150 | 2,830 | 2,175 | 1,564 | 0 | 0 | 0 | 0 |
Total operating expenses | |||||||||||||
23,333 | 22,081 | 20,144 | 17,774 | 14,333 | 11,916 | 9,197 | 8,318 | 6,584 | 4,772 | 0 | 0 | 0 | 0 |
Loss from operations | |||||||||||||
-23,333 | -22,081 | -20,144 | -17,774 | -14,333 | -11,916 | -9,197 | -8,318 | -6,584 | -4,772 | 0 | 0 | 0 | 0 |
Other Income | |||||||||||||
Interest and other income, net | |||||||||||||
3,015 | 2,993 | 2,705 | 1,852 | 1,483 | 1,027 | 622 | -2,775 | -2,992 | -3,148 | 0 | 0 | 0 | - |
Total interest and other income, net | |||||||||||||
- | - | - | 0 | - | - | - | -2,775 | -2,992 | -3,148 | 0 | 0 | 0 | - |
Net loss | |||||||||||||
-20,318 | -19,088 | -17,439 | -15,922 | -12,850 | -10,889 | 0 | 0 | 0 | - | - | - | 0 | 0 |
Unrealized gain on available-for-sale securities | |||||||||||||
8 | 8 | 12 | 17 | 0 | - | 0 | 0 | - | - | - | - | - | - |
Net loss applicable to stockholders and members | |||||||||||||
- | - | - | - | - | - | - | - | - | -7,920 | 0 | 0 | 0 | 0 |
Comprehensive loss | |||||||||||||
-20,310 | -19,080 | -17,429 | -15,902 | -12,834 | -10,887 | 0 | 0 | 0 | - | 0 | 0 | - | - |
Net loss per common share: Basic and diluted | |||||||||||||
-0.31 | -0.29 | -0.25 | -0.37 | -0.29 | -0.28 | -0.26 | -0.22 | -0.21 | 0.14 | -1.26 | -0.22 | -0.14 | -8.48 |
Weighted-average common shares outstanding: Basic and diluted | |||||||||||||
17,359 | 17,372 | 17,291 | 14,522 | 14,417 | 13,570 | 10,624 | 10,310 | 10,307 | 10,277 | 4,183 | 3,490 | 3,490 | 37 |